$ROIV
Roivant Sciences Ltd.

2024 Q1 Form 10-Q Financial Statement

#000114036124007260 Filed on February 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $28.93M $37.14M
YoY Change -52.79% 117.8%
Cost Of Revenue $4.412M $3.668M
YoY Change -66.39% 2.29%
Gross Profit $24.52M $33.47M
YoY Change -49.08% 148.57%
Gross Profit Margin 84.75% 90.12%
Selling, General & Admin $169.6M $197.3M
YoY Change -71.75% 17.25%
% of Gross Profit 691.8% 589.39%
Research & Development $120.9M $123.7M
YoY Change -80.59% -1.45%
% of Gross Profit 493.12% 369.61%
Depreciation & Amortization $5.225M $5.411M
YoY Change -12.23% 5.05%
% of Gross Profit 21.31% 16.17%
Operating Expenses $290.5M $324.7M
YoY Change -76.25% -17.83%
Operating Profit -$266.0M $5.061B
YoY Change -77.37% -1438.59%
Interest Expense $92.19M $9.444M
YoY Change -655.39% -65.97%
% of Operating Profit 0.19%
Other Income/Expense, Net -$33.06M $34.74M
YoY Change -46.84% 74.61%
Pretax Income -$191.5M $5.098B
YoY Change -84.37% -1434.37%
Income Tax -$8.957M $25.67M
% Of Pretax Income 0.5%
Net Earnings -$151.1M $5.096B
YoY Change -85.02% -1547.72%
Net Earnings / Revenue -522.35% 13721.55%
Basic Earnings Per Share $6.37
Diluted Earnings Per Share -$0.19 $6.03
COMMON SHARES
Basic Shares Outstanding 805.8M 803.9M
Diluted Shares Outstanding 844.5M

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.536B $6.671B
YoY Change 289.77% 336.73%
Cash & Equivalents $6.536B $6.671B
Short-Term Investments
Other Short-Term Assets $196.1M $135.9M
YoY Change 61.05% 14.42%
Inventory $35.25M $5.240M
Prepaid Expenses $55.10M $52.64M
Receivables $53.55M $41.08M
Other Receivables $29.27M $3.209M
Total Short-Term Assets $6.732B $6.807B
YoY Change 274.28% 313.47%
LONG-TERM ASSETS
Property, Plant & Equipment $19.06M $21.86M
YoY Change -51.24% -41.39%
Goodwill
YoY Change
Intangibles $137.8M $150.4M
YoY Change -4.86% 2.95%
Long-Term Investments $247.8M $239.9M
YoY Change -18.59% -11.94%
Other Assets $39.11M $46.85M
YoY Change -20.96% 1.35%
Total Long-Term Assets $490.7M $505.9M
YoY Change -16.98% -9.12%
TOTAL ASSETS
Total Short-Term Assets $6.732B $6.807B
Total Long-Term Assets $490.7M $505.9M
Total Assets $7.222B $7.313B
YoY Change 202.25% 231.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.23M $35.23M
YoY Change 40.7% -26.61%
Accrued Expenses $175.6M $122.1M
YoY Change 5.06% -7.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.00M $45.71M
YoY Change -70.53% 21.16%
Total Short-Term Liabilities $266.8M $244.9M
YoY Change -2.09% 0.26%
LONG-TERM LIABILITIES
Long-Term Debt $430.6M $403.3M
YoY Change 14.67% 7.52%
Other Long-Term Liabilities $3.602M $4.428M
YoY Change -78.85% -79.38%
Total Long-Term Liabilities $3.602M $4.428M
YoY Change -78.85% -79.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $266.8M $244.9M
Total Long-Term Liabilities $3.602M $4.428M
Total Liabilities $774.0M $728.1M
YoY Change -1.03% -6.15%
SHAREHOLDERS EQUITY
Retained Earnings $576.2M $727.3M
YoY Change -115.16% -119.66%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.969B $6.090B
YoY Change
Total Liabilities & Shareholders Equity $7.222B $7.313B
YoY Change 202.25% 231.95%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$151.1M $5.096B
YoY Change -85.02% -1547.72%
Depreciation, Depletion And Amortization $5.225M $5.411M
YoY Change -12.23% 5.05%
Cash From Operating Activities -$108.5M -$210.4M
YoY Change -39.44% -5.47%
INVESTING ACTIVITIES
Capital Expenditures $349.0K $333.0K
YoY Change -78.48% -34.45%
Acquisitions
YoY Change
Other Investing Activities $7.277M $5.233B
YoY Change -93.68% -174373.33%
Cash From Investing Activities $6.928M $5.233B
YoY Change -93.9% -149145.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -32.62M 236.7M
YoY Change -115.51% 53.2%
NET CHANGE
Cash From Operating Activities -108.5M -210.4M
Cash From Investing Activities 6.928M 5.233B
Cash From Financing Activities -32.62M 236.7M
Net Change In Cash -134.2M 5.259B
YoY Change -192.65% -7444.43%
FREE CASH FLOW
Cash From Operating Activities -$108.5M -$210.4M
Capital Expenditures $349.0K $333.0K
Free Cash Flow -$108.8M -$210.7M
YoY Change -39.79% -5.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40782
dei Entity Registrant Name
EntityRegistrantName
ROIVANT SCIENCES LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1173944
dei Entity Address Address Line1
EntityAddressAddressLine1
7th Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
50 Broadway
dei Entity Address City Or Town
EntityAddressCityOrTown
London
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
SW1H 0DB
dei Entity Address Country
EntityAddressCountry
GB
dei Country Region
CountryRegion
44
dei City Area Code
CityAreaCode
207
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Local Phone Number
LocalPhoneNumber
400 3347
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001635088
dei Document Type
DocumentType
10-Q
dei Security12b Title
Security12bTitle
Common Shares, $0.0000000341740141 per share
dei Trading Symbol
TradingSymbol
ROIV
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
805846006
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37140000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17052000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
95865000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33904000
CY2023Q4 roiv Operating Costs
OperatingCosts
3668000
CY2022Q4 roiv Operating Costs
OperatingCosts
3586000
roiv Operating Costs
OperatingCosts
11148000
roiv Operating Costs
OperatingCosts
8953000
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
123717000
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
125533000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
380834000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
393358000
CY2023Q4 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
0
CY2022Q4 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
97749000
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
26450000
roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
97749000
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
197282000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
168261000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
517827000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
474996000
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
324667000
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
395129000
us-gaap Operating Expenses
OperatingExpenses
936259000
us-gaap Operating Expenses
OperatingExpenses
975056000
CY2023Q4 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
5348410000
CY2022Q4 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
5348410000
roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
5060883000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-378077000
us-gaap Operating Income Loss
OperatingIncomeLoss
4508016000
us-gaap Operating Income Loss
OperatingIncomeLoss
-941152000
CY2023Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
-10467000
CY2022Q4 us-gaap Gain Loss On Investments
GainLossOnInvestments
25948000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-63880000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53277000
CY2023Q4 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-9331000
CY2022Q4 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-62360000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-85376000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-90032000
CY2023Q4 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0
CY2022Q4 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
12514000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
29276000
CY2023Q4 roiv Interest Income
InterestIncome
31953000
CY2022Q4 roiv Interest Income
InterestIncome
10249000
roiv Interest Income
InterestIncome
62967000
roiv Interest Income
InterestIncome
17900000
CY2023Q4 us-gaap Interest Expense
InterestExpense
9444000
CY2022Q4 us-gaap Interest Expense
InterestExpense
8446000
us-gaap Interest Expense
InterestExpense
27603000
us-gaap Interest Expense
InterestExpense
19393000
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34743000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18095000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33405000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11060000
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5098337000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-382077000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4444883000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1045618000
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25672000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2819000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31181000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8983000
CY2023Q4 us-gaap Profit Loss
ProfitLoss
5072665000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-384896000
us-gaap Profit Loss
ProfitLoss
4413702000
us-gaap Profit Loss
ProfitLoss
-1054601000
CY2023Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-23519000
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-32882000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-86339000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-79188000
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
5096184000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-352014000
us-gaap Net Income Loss
NetIncomeLoss
4500041000
us-gaap Net Income Loss
NetIncomeLoss
-975413000
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.37
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.39
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.03
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.39
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
800587716
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
713319399
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
776759728
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
703054773
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
844461685
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
713319399
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
824310013
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
703054773
CY2023Q4 us-gaap Profit Loss
ProfitLoss
5072665000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-384896000
us-gaap Profit Loss
ProfitLoss
4413702000
us-gaap Profit Loss
ProfitLoss
-1054601000
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-25066000
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8972000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-25612000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
547000
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-25066000
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8972000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-25612000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
547000
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5047599000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-393868000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4388090000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1054054000
CY2023Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-23873000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-32036000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-86784000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-78858000
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5071472000
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-361832000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4474874000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-975196000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
CY2023Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
-14395000
CY2023Q2 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
890000
CY2023Q2 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q2 roiv Dividend Declared By Subsidiary
DividendDeclaredBySubsidiary
6000000
CY2023Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49260000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4148000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-327845000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1334139000
CY2023Q3 roiv Stock Issued During Period Value Net Issuance Costs
StockIssuedDuringPeriodValueNetIssuanceCosts
199822000
CY2023Q3 roiv Stock Issued During Period Value Common Share Related To Settlement Of Warrants Value
StockIssuedDuringPeriodValueCommonShareRelatedToSettlementOfWarrantsValue
83264000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
587000
CY2023Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
20873000
CY2023Q3 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
35050000
CY2023Q3 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
196000
CY2023Q3 roiv Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0
CY2023Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
49318000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3602000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-331118000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1325633000
CY2023Q4 roiv Noncontrolling Interest Increase Decrease From Disposition
NoncontrollingInterestIncreaseDecreaseFromDisposition
87500000
CY2023Q4 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
-2456000
CY2023Q4 roiv Issuance Of Subsidiary Common Shares To The Company Net Issuance Costs Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyNetIssuanceCostsValue
238733000
CY2023Q4 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
3111000
CY2023Q4 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2023Q4 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
54550000
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-25066000
CY2023Q4 us-gaap Profit Loss
ProfitLoss
5072665000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6584582000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2038943000
CY2022Q2 roiv Issuance Of Subsidiary Common Shares To The Company Net Issuance Costs Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyNetIssuanceCostsValue
0
CY2022Q2 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
8329000
CY2022Q2 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2022Q2 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
72794000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5767000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-353784000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1755391000
CY2022Q3 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlans
0
CY2022Q3 roiv Stock Issued During Period Common Shares And Other Consideration For Acquisition Value
StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue
8948000
CY2022Q3 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2022Q3 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
0
CY2022Q3 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
61979000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3752000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-315921000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1514149000
CY2022Q4 roiv Stock Issued During Period Value Net Issuance Costs
StockIssuedDuringPeriodValueNetIssuanceCosts
94735000
CY2022Q4 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
982000
CY2022Q4 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2022Q4 roiv Issuance Of Subsidiary Common Shares To The Company Net Issuance Costs Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyNetIssuanceCostsValue
67728000
CY2022Q4 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
437000
CY2022Q4 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
292000
CY2022Q4 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
87500000
CY2022Q4 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
57731000
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8972000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-384896000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1427138000
us-gaap Profit Loss
ProfitLoss
4413702000
us-gaap Profit Loss
ProfitLoss
-1054601000
roiv Non Cash Acquired In Process Research And Development
NonCashAcquiredInProcessResearchAndDevelopment
0
roiv Non Cash Acquired In Process Research And Development
NonCashAcquiredInProcessResearchAndDevelopment
87749000
us-gaap Share Based Compensation
ShareBasedCompensation
152903000
us-gaap Share Based Compensation
ShareBasedCompensation
192504000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-63880000
us-gaap Gain Loss On Investments
GainLossOnInvestments
-53277000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-85376000
roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-90032000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
17354000
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
29276000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5348410000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16811000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12904000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5047000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6009000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
31846000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8066000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
18767000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
31037000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1797000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
13970000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15785000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5702000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6151000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6814000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-41986000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-3342000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656811000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-664305000
roiv Milestone Payments
MilestonePayments
0
roiv Milestone Payments
MilestonePayments
140136000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1033000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11068000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
47500000
us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0
roiv Proceeds From Sale Of Assets
ProceedsFromSaleOfAssets
5233396000
roiv Proceeds From Sale Of Assets
ProceedsFromSaleOfAssets
0
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
83679000
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
6706000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-511000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-88000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5196695000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-157822000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
199822000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
94735000
roiv Proceeds From Issuance Of Subsidiary Common Shares Net
ProceedsFromIssuanceOfSubsidiaryCommonSharesNet
238733000
roiv Proceeds From Issuance Of Subsidiary Common Shares Net
ProceedsFromIssuanceOfSubsidiaryCommonSharesNet
67727000
roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
0
roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
159899000
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
6000000
roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
0
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
21815000
roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
22108000
roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
0
roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
2250000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1225000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51023000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
569000
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
9101000
roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
9442000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
587000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
41000
roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
451988000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
289130000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1471000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4993343000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-532997000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2074034000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6685458000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1541037000
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
83258000
roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
0
roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
0
roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
9694000
roiv Noncash Other
NoncashOther
301000
roiv Noncash Other
NoncashOther
7063000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6700000000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
727300000
us-gaap Profit Loss
ProfitLoss
4400000000
us-gaap Profit Loss
ProfitLoss
-1100000000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6670810000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1676813000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5165000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9483000
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10291000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6685458000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P14Y9M18D
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
166471000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152629000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16056000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7748000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
150415000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144881000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2500000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10100000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10100000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
10100000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
10100000
CY2023Q4 roiv Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
107500000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
52642000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
60827000
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
41078000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
30379000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
5165000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5240000
CY2023Q1 us-gaap Inventory Net
InventoryNet
2761000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3209000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2356000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
18901000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
4909000
CY2023Q4 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
9688000
CY2023Q1 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
15531000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
135923000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
121774000
CY2023Q4 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
43627000
CY2023Q1 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
76278000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
41406000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55186000
CY2023Q4 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
16808000
CY2023Q1 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
17569000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20307000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18096000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
122148000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167129000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4695000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
12444000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
25223000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
542000
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1424000
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2090000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31342000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15076000
roiv Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
3
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.007
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
CY2023Q2 roiv Cashless Public Warrant Exercised
CashlessPublicWarrantExercised
20061507
CY2023Q2 roiv Class Of Warrant Or Right Unexercised Price Of Warrants
ClassOfWarrantOrRightUnexercisedPriceOfWarrants
413971
CY2023Q2 roiv Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.1
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
5096184000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-352014000
us-gaap Net Income Loss
NetIncomeLoss
4500041000
us-gaap Net Income Loss
NetIncomeLoss
-975413000
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
800587716
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
713319399
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
776759728
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
703054773
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43873969
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
47550285
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
844461685
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
713319399
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
824310013
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
703054773
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.37
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.39
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.03
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.39

Files In Submission

Name View Source Status
0001140361-24-007260-index-headers.html Edgar Link pending
0001140361-24-007260-index.html Edgar Link pending
0001140361-24-007260.txt Edgar Link pending
0001140361-24-007260-xbrl.zip Edgar Link pending
ef20015327_10q.htm Edgar Link pending
ef20015327_ex31-1.htm Edgar Link pending
ef20015327_ex31-2.htm Edgar Link pending
ef20015327_ex32-1.htm Edgar Link pending
ef20015327_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
ef20015327_10q_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20231231.xsd Edgar Link pending
Show.js Edgar Link pending
roiv-20231231_pre.xml Edgar Link unprocessable
roiv-20231231_def.xml Edgar Link unprocessable
roiv-20231231_lab.xml Edgar Link unprocessable
roiv-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable